key: cord-0904752-s76nxaux authors: Guner Ozenen, Gizem; Sahbudak Bal, Zumrut; Umit, Zuhal; Bilen, Nimet Melis; Yildirim Arslan, Sema; Yurtseven, Ali; Saz, Eylem Ulas; Burcu, Barutcuoglu; Sertoz, Ruchan; Kurugol, Zafer; Ozkinay, Ferda title: Demographic, clinical, and laboratory features of COVID‐19 in children: The role of mean platelet volume in predicting hospitalization and severity date: 2021-03-11 journal: J Med Virol DOI: 10.1002/jmv.26902 sha: 78ad7b188ece383b68f24d5dc7565bdf9297d1c7 doc_id: 904752 cord_uid: s76nxaux There have been a limited number of studies on coronavirus disease 2019 (COVID‐19) in children. In this study, we aimed to investigate the demographic, clinical, and laboratory features of COVID‐19 and to identify the role of mean platelet volume (MPV) in predicting the prognosis in children. A single‐center retrospective study, including 251 confirmed and 65 suspected COVID‐19 cases, was conducted between March 11, 2020, and December 11, 2020. In the confirmed COVID‐19 group, 48 (19.1%) patients were asymptomatic, 183 (72.9%) mild, 16 (6.4%) moderate, 1 (0.4%) severe, and 3 were (1.2%) critically ill. Confirmed COVID‐19 patients had significantly lower mean values of white blood cell (WBC), absolute neutrophil count, absolute lymphocyte count, platelet, and hemoglobin (p < .001). However, there was no significant difference in MPV levels between the two groups (p = .894). C‐reactive protein (CRP), procalcitonin, fibrinogen, and NT‐pro‐BNP mean values were significantly lower in confirmed COVID‐19 cases than suspected cases (p < .001). A total of 55 (21.9%) patients required hospitalization due to COVID‐19, and MPV, WBC, CRP, procalcitonin, D‐dimer, and NT‐pro‐BNP were statistically higher in hospitalized patients than those in outpatients. The multivariate analysis of confirmed COVID‐19 cases according to the severity of disease showed that lymphopenia and higher levels of fibrinogen significantly associated with severe clinical symptoms. Decision tree analysis showed that the most powerful predictor of hospitalization due to COVID‐19 was the D‐dimer (p < .001). MPV values are not associated with COVID‐19 disease severity. However, MPV can be used with other parameters such as WBC, CRP, procalcitonin, D‐dimer, and NT‐pro‐BNP to predict hospitalization. In December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China. 1, 2 The first case of coronavirus disease 2019 (COVID- 19) was reported on March 11, 2020, in Turkey. 3 Reports on COVID-19 primarily focus on adults, but COVID-19 cases are also seen in pediatric patients. 4, [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] often presents as an asymptomatic or milder disease in children and has a better prognosis than adults; however, it should be kept in mind that it may be severe in infants under 1 year of age and children with chronic diseases. 6 In children, the milder presentation of COVID-19 can be explained by the fact that children have a different immune response to the SARS-CoV-2 virus than adults and the common viruses in the mucosa of the respiratory system limit the growth of SARS-CoV-2 with virus interactions. 6, 7 Several studies showed that the hyperinflammatory response induced by SARS-CoV-2 is a major cause of disease severity and death in infected patients. 8, 9 Higher levels of inflammatory markers in blood including C-reactive protein (CRP), ferritin, D-dimer, an increased neutrophil-to-lymphocyte ratio (NLR), increased levels of several inflammatory cytokines, and chemokines have been associated with disease severity. 9,10 Lower platelet count and increased level of D-dimer are associated with coagulation abnormalities leading to organ failure and death in patients with severe COVID- 19. 8 Recently, it has been reported that platelets have important functions in inflammation, and mean platelet volume (MPV), which is a parameter evaluated in complete blood count (CBC), can be used as an inflammatory marker in some inflammatory diseases. 11 MPV shows the size of platelets and it is correlated with platelet activation and function, and usually increases in patients with thrombosis. 12 Inflammatory mediators, such as interleukin-6, which usually increases in acute or chronic conditions, may affect the bone marrow by changing the whole megakaryocytic platelet axis causing higher MPV levels. 11, 12 MPV can give information on the course and prognosis in several pathological conditions, such as cardiovascular, respiratory, and rheumatological diseases. [12] [13] [14] [15] [16] [17] [18] Significant differences in MPV levels have also been shown in respiratory diseases accompanied by inflammatory conditions. [14] [15] [16] [17] [18] In a recent study by Canpolat et al., 14 MPV has been shown to have higher levels in premature infants with respiratory distress syndrome (RDS) than infants without RDS. In another study, Nakoa et al. 15 reported that patients with tonsillitis and peritonsillar abscess have lower levels of MPV. Renshaw et al. 16 showed that decreased MPV levels are associated with respiratory syncytial virus infection. It has also been shown that children with acute bronchiolitis have higher levels of MPV than controls, and patients with active tuberculosis have lower MPV levels as compared with patients having latent infection. 18, 19 MPV has been considered to be an inflammatory biomarker in several diseases; however, there have been a limited number of studies on MPV and its potential role in predicting the severity of COVID-19 in children. In this study, the demographic, clinical, and laboratory features of COVID-19 and the role of MPV in predicting the prognosis in children have been investigated. D-dimer was found to be the most powerful predictor of hospitalization due to COVID-19. MPV can be a valuable parameter in predicting patients requiring hospitalization, along with other parameters such as white blood cell count, CRP, procalcitonin, D-dimer, and NT-pro-BNP. A single-center retrospective study was conducted between March 11, 2020, and December 11, 2020, in Ege University Children's Hospital, which is a tertiary level hospital in the west part of Turkey. COVID-19 was diagnosed according to the Turkey Ministry of Health COVID-19 Guideline and confirmed cases were defined as the cases in which SARS-CoV-2 was detected by molecular methods from throat swab specimens. 3 The patients with two consecutive negative also recorded. Thrombocytopenia was defined as a blood platelet count less than 150 × 10 9 /L, neutropenia was defined as ANC less than 1500/mm 3 , and lymphopenia was defined as absolute lymphocyte count less than 1500/mm 3 . NLR was calculated from a CBC test Statistical analysis was performed with SPSS statistical package (version 25 for Windows). Data were expressed as means ± SD or medians (interquartile range) for continuous variables or percentages for categorical variables. Group comparisons were made using the Student's t test for normally distributed data and the χ 2 test for categorical data. The Mann-Whitney U test was used to compare differences in nonparametric data between the groups. Differences and correlations were considered significant at p < .05. Univariate and multivariate analyses of predictors for illness severity were performed using the logistics regression. All variables with a p value of less than .05 were included in the multivariate analysis, and the results of this regression analyses were reported as adjusted odds ratio with a 95% confidence interval. Significant predictors for hospitalization due to COVID-19, as retrieved from SPSS analysis, were also evaluated with the MedCalc program. Also, MedCalc program was also used to determine the area under the curve (AUC), sensitivity, specificity, and positive and negative predictive values. Decision tree models were generated using the exhaustive χ 2 automatic interaction detector algorithm. The study groups consisted of 251 patients with confirmed and 65 suspected COVID-19 cases. In confirmed COVID-19 patients, the median age was 8.92 ± 6.01 years and 55.5% of them were male. In total, 183 (72.9%) patients were previously healthy. The most common underlying disease in confirmed COVID-19 patients was chronic pulmonary disease (4.4%), followed by neurologic disease (3.6%) and bone marrow/solid organ transplantation (3.2%). The most common symptom was fever (57%), followed by cough (23.9%) and myalgia ( there were no statistical differences in MPV levels between the groups when they were compared according to the severity of the disease. Comparison of MPV values and mortality could not be made because there were no deaths. However, in our study, hospitalized patients due to confirmed COVID-19 had significantly higher mean values of MPV, WBC, CRP-PCT, and D-dimer than those in confirmed COVID-19 outpatients. Decision tree analysis showed that F I G U R E 2 ROC curves of WBC, CRP, procalcitonin, D-dimer, NT-pro-BNP, and MPV in predicting hospitalization due to COVID-19. COVID-19, coronavirus disease 2019; CRP, C-reactive protein; MPV, mean platelet volume; NT-pro-BNP, N-terminal-probrain natriuretic peptide; ROC, receiver operating characteristic curve; WBC, white blood cell A pneumonia outbreak associated with a new coronavirus of probable bat origin Clinical features of patients infected with 2019 novel coronavirus in Wuhan Turkey Ministry of Health, General Directorate of Public Health. COVID-19 Guide Epidemiology and clinical features of coronavirus disease 2019 in children Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) infection in children and adolescents: a systematic review Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages The role of biomarkers in diagnosis of COVID-19-a systematic review Laboratory data analysis of novel coronavirus (COVID-19) screening in 2510 patients [published online ahead of print New roles for mean platelet volume measurement in the clinical practice? Mean platelet volume (MPV): new perspectives for an old marker in the course and prognosis of inflammatory conditions Altered mean platelet volume in children with Henoch-Schonlein purpura and its association with disease activity Mean platelet volume in neonatal respiratory distress syndrome Diagnostic role of mean platelet volume in tonsillitis with and without peritonsillar abscess Respiratory syncytial virus infection is strongly correlated with decreased mean platelet volume A decreased mean platelet volume is associated with stable and exacerbated asthma Mean platelet volume as an inflammation marker in active pulmonary tuberculosis The role of mean platelet volume in the early detection of acute bronchiolitis: a prospective study Epidemiology of COVID-19 among children in China COVID-19 Diagnostic and Management Protocol for Pediatric Patients Association between platelet parameters and mortality in coronavirus disease 2019: retrospective cohort study Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus Can routine laboratory tests discriminate SARS-CoV-2-infected pneumonia from other causes of communityacquired pneumonia? Children with coronavirus disease 2019: a review of demographic, clinical, laboratory, and imaging features in pediatric patients Characteristics and management of children with COVID-19 in Turkey SARS-CoV-2 infection in children Effect of COVID-19 on platelet count and its indices How to cite this article: Guner Ozenen G Demographic, clinical, and laboratory features of COVID-19 in children: The role of mean platelet volume in predicting hospitalization and severity The authors declare that there are no conflict of interests. The peer review history for this article is available at https://publons. com/publon/10.1002/jmv.26902 The data that support the findings of this study are available from the corresponding author upon reasonable request.